Sporotrichosis laboratory findings

Jump to navigation Jump to search

Sporotrichosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sporotrichosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Treatment

Medical Therapy

Surgery

Prevention

Case Studies

Case #1

Sporotrichosis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sporotrichosis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sporotrichosis laboratory findings

CDC on Sporotrichosis laboratory findings

Sporotrichosis laboratory findings in the news

Blogs on Sporotrichosis laboratory findings

Directions to Hospitals Treating Sporotrichosis

Risk calculators and risk factors for Sporotrichosis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Laboratory findings

  • Sporotrichosis is a chronic disease with slow progression and often subtle symptoms. It is difficult to diagnose, as many other diseases share similar symptoms and therefore must be ruled out.
  • While within human and animal tissues, S. schenckii exists in its yeast form.
  • Varying in size and shape, these curved cells typically have 2-6 μm diameters with cigar-like buds offshooting from a narrow base.
  • Growing on Sabouraud dextrose agar, most S. schenckii strains become evident after 4 days. At this point, some strains lack dark pigment, while others have been infiltrated with dark pigment from the start. Upon transfer to Brain-Heart Infusion (BHI) agar, and cultured for 7 days at 37°C, the S. schenckii strains undergo dimorphism, manifesting as creamy off-white to beige colored colonies.
  • Patients with sporotrichosis will likely have antibodies against the fungus S. schenckii, however, due to variability in sensitivity and specificity, antibody identification may not be a reliable diagnosis for this disease. The confirming diagnosis remains culturing the fungus from the skin, sputum, synovial fluid, and cerebrospinal fluid.
  • Cats with sporotrichosis are unique in that the exudate from their lesions may contain numerous organisms. This makes cytological evaluation of exudate a valuable diagnostic tool in this species. Exudate is pyogranulomatous and phagocytic cells may be packed with yeast forms. These are variable in size, but many are cigar-shaped.[1]

References

  1. Alvarado-Ramírez E, Torres-Rodríguez JM (2007). "In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods". Antimicrob Agents Chemother. 51 (7): 2420–3. doi:10.1128/AAC.01176-06. PMC 1913275. PMID 17438048.